Affinity Asset Advisors’s Q32 Bio QTTB Stock Holding History

Affinity Asset Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$178K	Hold	27,777	–	–	0.01%	103
2025 Q4	$92.2K	Hold	27,777	–	–	0.01%	93
2025 Q3	$55K	Hold	27,777	–	–	﹤0.01%	94
2025 Q2	$41.4K	Hold	27,777	–	–	0.01%	88
2025 Q1	$45.8K	Hold	27,777	–	–	﹤0.01%	96
2024 Q4	$95.6K	Hold	27,777	–	–	0.01%	81
2024 Q3	$1.24M	Hold	27,777	–	–	0.17%	71
2024 Q2	$499K	Hold	27,777	–	–	0.06%	88
2024 Q1	$473K	Buy	+27,777	New	+$383K	0.06%	89

Other funds holding QTTB

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Affinity Asset Advisors's QTTB Position: Q1 2026 in Review

Affinity Asset Advisors held its Q32 Bio (QTTB) position steady in Q1 2026 at 27,777 shares worth $178K. The position accounts for 0.01% of the portfolio, ranked #103.

Affinity Asset Advisors first reported a position in QTTB in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.24M in Q3 2024. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

Affinity Asset Advisors held 27,777 shares of Q32 Bio worth $178K as of Q1 2026.
Affinity Asset Advisors left its Q32 Bio share count unchanged in Q1 2026.
Q32 Bio made up 0.01% of Affinity Asset Advisors's portfolio in Q1 2026, its #103 holding.
Affinity Asset Advisors first reported a position in Q32 Bio in Q1 2024 and has held it in 9 quarters since.
Affinity Asset Advisors's Q32 Bio position peaked at $1.24M in Q3 2024.
54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Affinity Asset Advisors's 13F filing for Q1 2026, filed 14 May 2026.